跳至主要内容
临床试验/NCT03670680
NCT03670680已完成不适用

Evaluation of the Efficiency of Lina LibrataTM System in the Treatment of Functional Idiopathic Menometrorrhagia

Hospices Civils de Lyon2 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2018年10月16日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
38
试验地点
2
主要终点
rate of amenorrhea

研究概览

简要总结

Menometrorrhagia is the first cause of consultation in gynecology. Etiology of menometrorrhagia is varied, but in majority of cases no underlying pathology is found, they are said functional idiopathic menometrorrhagia .

In case of failure of medical treatment, for women who do not wish to preserve reproduction possibilities, a surgical treatment by endometrectomy (destruction of the uterine endometrial epithelial) can be proposed. Currently, a new system, Lina LibrataTM is available on the market. This system allows destructing endometrial membrane with a balloon which offer several advantages compared to present used system. Specially, it does not require dilatation of uterus's cervix and it reduces the pain. The investigator make hypothesis that the use of the system Lina LibrataTM does not cause pain and can be thus used under local anesthetic in ambulatory surgery. With the aim of developing ambulatory care, the main objective of this prospective monocentric study is to estimate the efficiency of Lina LibrataTM system in the treatment of functional idiopathic menometrorrhagia. Secondary objectives are to estimate the pain during the procedure, the rate of per and post-complications and quality of life.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
38 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women from 40 to 50 years old
  • Not menopausal women
  • Do not want pregnancy
  • Having dysfunctional bleeding
  • informed and signed consent

排除标准

  • Unacceptable postoperative risk disclosed on interview: coagulation disorder, immune disorder, evolutive disease, etc
  • Pregnancy or wish to have later pregnancy
  • Endometrium cancer (or suspicious of cancer) or precancerous conditions of the endometrium
  • Anatomical conditions (i-e history of caesarian, transmural myomectomy) or pathological conditions (i-e long term treatment) which can weaken myometrium
  • Genital or urinary infection at the time of the procedure
  • Intra uterine device
  • Pelvic inflammation
  • Inability to understand information provided
  • Not covered by a national health insurance scheme, prisoner or under administrative supervision

结局指标

主要结局

rate of amenorrhea

时间窗: 4 weeks

次要结局

  • assessment of menorrhagia on Higham's score(6 months after surgery)
  • per-operative complications(per surgery day 0)
  • post-operative complications(post surgery day 0)
  • evolution of hemoglobinemia(6 months after surgery)
  • measure of symptoms improvement(at month 6)
  • recurrences of menorrhagia(at month 6)
  • measure of quality of life(at month 6)
  • pain score(one month after surgery (Month 1))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验